End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice

New therapeutic approaches for castration-resistant prostate cancer (CRPC) introduce new treatment dilemmas: how best to sequence these options to maximally benefit patients, what tests to perform before and after treatment to assess disease status, and how to interpret the test results and use them...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Scher, Howard I., Morris, Michael J., Basch, Ethan, Heller, Glenn
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2011
Schlagworte:
Special Series: Prostate Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675708/
https://ncbi.nlm.nih.gov/pubmed/21859988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.35.8648
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge